This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Corteva, Inc. provides agriculture products. The company develops and supplies germplasm and traits in corn, soybean and sunflower seed markets. It also supplies products to the agricultural input industry which protect against weeds, insects and other pests, and diseases as well as to enhance crop health. Corteva, Inc. is based in Wilmington, Delaware.
CTVA Announces Financial Framework & New $3-B Share Repurchase Plan
by Zacks Equity Research
Corteva highlights its financial framework through 2027. The company approves a new $3-billion share repurchase authorization.
Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y
by Zacks Equity Research
RKDA witnesses a solid 55% improvement in Zola sales in Q3. The company continues to invest to grow the Zola brand.
Zacks Industry Outlook Corteva, Dole, Adecoagro and Calavo Growers
by Zacks Equity Research
Corteva, Dole, Adecoagro and Calavo Growers have been highlighted in this Industry Outlook article.
4 Key Agriculture Stocks Positioned for Gains as Market Trends Improve
by Rajani Lohia
The Agriculture - Operations industry is set to grow on innovation and rising demand for healthy products despite challenges from increasing costs and trade uncertainties. Companies such as CTVA, DOLE, AGRO and CVGW are well-positioned to benefit from these trends.
Here's What Key Metrics Tell Us About Corteva, Inc. (CTVA) Q3 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Corteva, Inc. (CTVA) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Corteva, Inc. (CTVA) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of -58.06% and 13.39%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Cadiz (CDZI) Report Negative Q3 Earnings? What You Should Know
by Zacks Equity Research
Cadiz (CDZI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insights Into Corteva, Inc. (CTVA) Q3: Wall Street Projections for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Corteva, Inc. (CTVA) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Analysts Estimate Corteva, Inc. (CTVA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Corteva, Inc. (CTVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top 4 Agriculture Operations Stocks to Watch as Industry Trends Improve
by Rajani Lohia
The Agriculture - Operations industry is poised to grow on innovation and healthy product demand amid rising costs and trade uncertainties. Companies like CTVA, DOLE, AGRO, and ALCO are expected to benefit from innovations and increased consumer demand.
Should You Invest in the VanEck Agribusiness ETF (MOO)?
by Zacks Equity Research
Sector ETF report for MOO
Arcadia Biosciences (RKDA) Q2 Earnings Miss, Increase Y/Y
by Zacks Equity Research
Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains.
Compared to Estimates, Corteva, Inc. (CTVA) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Corteva, Inc. (CTVA) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Corteva, Inc. (CTVA) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 5.17% and 0.14%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Unlocking Q2 Potential of Corteva, Inc. (CTVA): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Corteva, Inc. (CTVA) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Corteva, Inc. (CTVA) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Corteva, Inc. (CTVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AGRO or CTVA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AGRO vs. CTVA: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights Corteva, Archer Daniels Midland, Alico and Adecoagro
by Zacks Equity Research
Corteva, Archer Daniels Midland, Alico and Adecoagro have been highlighted in this Industry Outlook article.
4 Agriculture Operations Stocks to Watch Amid Elevated Costs
by Rajani Lohia
The Agriculture - Operations industry participants are witnessing higher costs due to fluctuating commodity prices, rising input costs and trade uncertainties. Innovations and improved consumer demand are likely to aid companies like CTVA, ADM, ALCO and AGRO.
Compared to Estimates, Corteva, Inc. (CTVA) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Corteva, Inc. (CTVA) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Should You Invest in the VanEck Agribusiness ETF (MOO)?
by Zacks Equity Research
Sector ETF report for MOO
Insights Into Corteva, Inc. (CTVA) Q1: Wall Street Projections for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Corteva, Inc. (CTVA) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Corteva, Inc. (CTVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Corteva, Inc. (CTVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wall Street Bulls Look Optimistic About Corteva, Inc. (CTVA): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Corteva, Inc. (CTVA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Cibus (CBUS) Moves 6.7% Higher: Will This Strength Last?
by Zacks Equity Research
Cibus (CBUS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.